Literature DB >> 12908773

Human infection with foamy viruses.

W Heneine1, M Schweizer, P Sandstrom, T Folks.   

Abstract

Virtually all nonhuman primate species investigated thus far including prosimians, New World and Old World monkeys and apes all harbor distinct and species-specific clades of simian foamy virus (SFV). However, evidence supporting the existence of a human-specific foamy virus (FV) is not yet available. Early reports describing widespread infection of healthy and sick humans with FV could not be confirmed. In contrast, all FV infections documented in humans are of zoonotic origin and are identified in persons occupationally exposed to nonhuman primates. The introduction of SFV into humans raises several public health questions regarding disease outcomes and potential for human-to-human transmissibility. The available data from a very limited number of SFV-infected humans suggest that these infections are nonpathogenic and are not easily transmissible. Additional studies are needed to better define the prevalence and natural history of SFV in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908773     DOI: 10.1007/978-3-642-55701-9_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  39 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Foamy virus vector integration sites in normal human cells.

Authors:  Grant D Trobridge; Daniel G Miller; Michael A Jacobs; James M Allen; Hans-Peter Kiem; Rajinder Kaul; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-20       Impact factor: 11.205

4.  Restriction of foamy viruses by APOBEC cytidine deaminases.

Authors:  Frédéric Delebecque; Rodolphe Suspène; Sara Calattini; Nicoletta Casartelli; Ali Saïb; Alain Froment; Simon Wain-Hobson; Antoine Gessain; Jean-Pierre Vartanian; Olivier Schwartz
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 6.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

Review 7.  Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Authors:  Joachim Denner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

8.  Foamy virus as a gene transfer vector to the central nervous system.

Authors:  A V Caprariello; R H Miller; S M Selkirk
Journal:  Gene Ther       Date:  2008-12-04       Impact factor: 5.250

9.  Accuracy estimation of foamy virus genome copying.

Authors:  Kathleen Gärtner; Tatiana Wiktorowicz; Jeonghae Park; Ayalew Mergia; Axel Rethwilm; Carsten Scheller
Journal:  Retrovirology       Date:  2009-04-06       Impact factor: 4.602

10.  Simian foamy virus transmission from apes to humans, rural Cameroon.

Authors:  Sara Calattini; Edouard Betsem A Betsem; Alain Froment; Philippe Mauclère; Patricia Tortevoye; Christine Schmitt; Richard Njouom; Ali Saib; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.